CRISPR and Genome Editing – News and Features
News
Significant Technological Challenges Remain for the Development of RNA-Based Therapeutics
In this Decision Resources report three RNA-based technologies are described.
News
Researchers Develop Remote Control Gene Expression Tool
This versatile package can carry bits of RNA that stop the cell from expressing one of its own genes.
News
Sigma-Aldrich Expands shRNA Libraries of the RNAi Consortium
The collection now carries 65,000 shRNA vector constructs that target 9,500 human genes and 3,400 mouse genes.
News
Lentigen and ZGene Enter License Agreement for Selected ZGene Intellectual Property
Lentigen gains exclusive, world-wide license to multisubstrate kinase gene technology.
News
Genzyme Strengthens Its Gene Therapy Program
Genzyme bought extensive gene therapy assets from US company Avigen in December.
News
Sangamo Announces Expansion of Research Collaboration Agreement with Pfizer
Sangamo will use its ZFP technology to develop cell lines for enhanced protein production.
News
Dharmacon and MIT Settle RNAi License Dispute
MIT has dismissed all of its legal claims against Dharmacon and its parent company Fisher Scientific International Inc.
News
Gene Therapy for Muscular Dystrophy Fixes Frail Muscle Cells in Animal Model
Researchers used gene therapy to introduce a healthy copy of the gene dystrophin into mice with a condition that mimics muscular dystrophy.
News
Researchers Demonstrate new way to Switch Therapeutic Genes 'On' and 'Off'
Researchers have created a genetic switch system that is turned on in the presence of the antibiotic tetracycline.
News
Sickle Cell Disease Corrected in Human Models Using Stem Cell-based Gene Therapy
This research demonstrates a way to genetically correct sickle cell disease using RNAi technology.
Advertisement
